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Abstract
The Space Shuttle Atlantis launched on its final mission (STS-135) on July 8, 2011. After
just under 13 days, the shuttle landed safely at Kennedy Space Center (KSC) for the last
time. Female C57BL/6J mice flew as part of the Commercial Biomedical Testing Module-3
(CBTM-3) payload. Ground controls were maintained at the KSC facility. Subsets of these
mice were made available to investigators as part of NASA’s Bio-specimen Sharing Pro-
gram (BSP). Our group characterized cell phenotype distributions and phagocytic function
in the spleen, catecholamine and corticosterone levels in the adrenal glands, and transcrip-
tomics/metabolomics in the liver. Despite decreases in most splenic leukocyte subsets,
there were increases in reactive oxygen species (ROS)-related activity. Although there were
increases noted in corticosterone levels in both the adrenals and liver, there were no signifi-
cant changes in catecholamine levels. Furthermore, functional analysis of gene expression
and metabolomic profiles suggest that the functional changes are not due to oxidative or
psychological stress. Despite changes in gene expression patterns indicative of increases
in phagocytic activity (e.g. endocytosis and formation of peroxisomes), there was no corre-
sponding increase in genes related to ROS metabolism. In contrast, there were increases in
expression profiles related to fatty acid oxidation with decreases in glycolysis-related pro-
files. Given the clear link between immune function and metabolism in many ground-based
diseases, we propose a similar link may be involved in spaceflight-induced decrements in
immune and metabolic function.
Introduction
The final US Space Shuttle mission, STS-135, launched on July 8, 2011. After 12 days, 18 hours
and 29 minutes, Space Shuttle Atlantis landed safely at Kennedy Space Center (KSC) for the
last time. One of the many experiments flown on this historic flight to the International Space
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Station (ISS) was BioServe Space Technology’s Commercial Biomedical Testing Module-3
(CBTM-3). Sponsored by Amgen, Inc., the last animal flight of the shuttle era was intended to
test the impact of their proprietary pharmaceutical agent on spaceflight-induced musculoskel-
etal atrophy. Participants in the NASA Biospecimen Sharing Program (BSP) were given the
opportunity to analyze a subset of the placebo-treated mice (n = 5–10, depending on the assay
and tissue) as long as it did not interfere with the primary science. Our research team at Loma
Linda University (LLU) has participated in all three Amgen/CBTM flights (STS-108, -118, and
-135) [1–6], giving us the unique opportunity to both repeat and expand on previous results.
There are at least three, currently unavoidable components of the spaceflight environment
that directly impact immune function. These include changes in the inertial environment (e.g.
launch and landing loads, microgravity), low-dose/low-dose-rate radiation (e.g. solar particle
events, galactic cosmic rays, and the Van Allen belts), and physiological/psychological stress
(e.g. unloading, work-related stress). Ground-based studies have shown that each of these
environmental factors alone can have an impact on immune function.
Previously, we and others have shown that the spaceflight environment can have a dramatic
influence on immunity. Virtually all immune populations are reduced after spaceflight [2, 4].
Studies in both animal models and humans have shown that the spaceflight environment can
influence total body, thymus and spleen mass [7–18], lymphocyte population distributions
[18–25] and circulating corticosterone levels [16, 17, 26–33].
Interestingly, spaceflight is also known to alter energy/lipid metabolism [34, 35] and
ground-based studies suggest that the stress marker, corticosterone/cortisol, plays a significant
role [36]. Corticosterone promotes fat breakdown in adipose and muscle tissues to provide
glycerol to the liver for gluconeogenesis [36]. As we demonstrate, metabolomic analysis of the
liver indicates that glycerol was more abundant in flight mice relative to ground controls. Fur-
thermore, data from the liver, skin and adrenal gland suggest that spaceflight caused a signifi-
cant increase in corticosterone levels system-wide.
These seemingly unrelated lines of investigation are important because there is a growing
body of work describing the interaction between innate immunity and lipid metabolism (S1
Fig). Chronic inflammation is now accepted as a critical component in many pathologies and
chronic diseases. Macrophages are not only among the first responders in host resistance to
infection, but also have an underappreciated role in host health when metabolic changes occur
[37]. For example, in obese people, increased numbers of liver and adipose tissue macrophages
correlate with the development of metabolic syndrome [38].
In the current study we describe a more systemic response to microgravity by combining
traditional measures of innate immune function (population distributions, oxidative burst
capacity, phagocytosis) and stress responses (adrenal catecholamine and corticosterone levels)
with ‘omics techniques (metabolomics and transcriptomics). We believe that, for the first time,
we can begin to show the links between spaceflight-dependent immune dysfunction and
changes in metabolism.
Methods
Mice and treatment
On July 8, 2011, age- and weight-matched, 11 week old, female C57BL/6J mice (n = 15/group)
were placed into three Animal Enclosure Modules (AEMs, 2 groups of 5 per AEM separated
by a wire mesh) and flown on the Space Shuttle Atlantis (STS-135) for ~13 days. There were
two sets of ground controls housed at the Space Life Science Laboratory (SLSL) at KSC:
Ground AEM controls (n = 10) and Vivarium controls (n = 8). Due to the nature of the NASA
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Biospecimen Sharing Program (BSP), we did not receive tissues from all mice for all assays.
Sample sizes for individual assays are indicated where appropriate.
Ground AEM control mice were placed into the same hardware used in flight and environ-
mental parameters such as temperature and CO2 levels were matched as closely as possible
based on 48-hour delayed telemetry data. Conditions were controlled for temperature, humid-
ity, and a 12:12 hr light:dark cycle; food (food bars developed by NASA Ames) and water was
provided ad libitum. Vivarium control mice, housed in standard shoebox cages and fed stan-
dard rodent chow, were used to normalize cell counts, thus minimizing day-to-day variability.
Mice were euthanized and dissected within 3–5 hours of landing. As part of the primary sci-
ence, all mice underwent dual energy X-ray absorptiometry (DEXA) densitometry (Piximus,
Inc., Fitchburg, WI) immediately prior to anesthesia and euthanization. Mice were anesthe-
tized with 3–5% isoflurane and euthanized with 100% CO2 and exsanguination via cardiac
puncture. Samples were shipped to either LLU or University of Colorado Anschutz Medical
Campus and stored appropriately prior to use. These studies were approved by the NASA
Ames and University of Colorado at Boulder Institutional Animal Care and Use Committees
(IACUCs).
Tissue handling
Each spleen was cut in half at the time of dissection, placed into complete Roswell Park Memo-
rial Institute-1640 (RPMI-1640) medium with 20% bovine calf serum and shipped on ice via
overnight courier to LLU for further processing. Note: There was a problem with the courier
shipping fresh tissues from the ground control mice from KSC to LLU. As a result, “fresh” ground
control splenocyte samples were processed and assayed at LLU 48 hours after tissue collection. In
contrast, “fresh” flight samples were processed and assayed roughly 24 hours post-tissue collection.
This must be considered in interpreting all assays involving “fresh” splenocytes presented below.
Only the assays that involved fresh splenic tissue were affected by this shipping error. These
include flow cytometry, oxidative burst, background ROS, and phagocytosis assays.
Adrenals were snap frozen in liquid nitrogen at the time of dissection and stored at -80˚C
until analysis. Liver lobes were extracted and dissected at the time of dissection. A portion of
the sample was prepared in 4% paraformaldehyde. The rest of the liver was snap frozen in liq-
uid nitrogen and stored at -80˚C until analysis. Note: none of the liver or adrenal tissues were
impacted by the shipping error.
Splenocyte viability
Spleen cell concentration was adjusted to 2 x 106 cells/ml and mixed with 0.4% trypan blue
solution. The cell suspension was loaded onto CHT4 counting chamber slides and viability
was assessed via the Cellometer Auto T4 (Nexcelcom Bioscience LLC, Lawrence, MA).
Splenic leukocyte quantification
Splenocyte single-cell suspensions were diluted in RPMI-1640 medium and evaluated using
the ABC Vet Hematology Analyzer (Heska Corp., Waukesha, WI) after lysis of erythrocytes by
incubation in 2 ml of ammonium-chloride-potassium solution for 4 min at 4˚C.
Immunophenotyping of lymphocyte subsets was performed on spleen using a FACSCali-
burTM flow cytometer (Becton Dickinson, Inc., San Jose, CA). Monoclonal antibodies (MAb;
BD Pharmingen, Inc., San Diego, CA) were labeled with fluorescein isothiocyanate (FITC), R-
phycoerythrin (PE), allophycocyanin (APC), or peridinin chlorophyll protein (PerCP). MAb
were directed against the following markers: CD3 (G4.18)–mature T cells; CD4 (OX-35)–T
helper (Th) cells; CD8 (OX-8)–T cytotoxic (Tc) cells; CD45 (OX-1)–leukocytes; CD45R
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(HIS24)–B cells. We gated on the mononuclear population on a CD45 vs side scatter dot plot.
At least 5,000 gated events/tube were evaluated using CellQuestTM software version 3.1 (Bec-
ton Dickinson).
All cell count numbers were normalized to Vivarium controls and combined for the final
analysis using the following equation: Final Data Point = [Measured Data Point] / [Average of
Daily Vivarium Control]  [Average of All Controls for All Experiments].
Splenocyte oxidative burst and background reactive oxygen species
(ROS)–plate reader
Spleen white blood cells (WBCs) were treated with zymosan A (for burst activity; Sigma
Chemical Co., St. Louis, MO) or medium (for background activity), and 2’,7’-dichlorodihydro-
fluorescein diacetate (DCFH-DA; Molecular Probes, Inc., Eugene, OR), a membrane-perme-
able diacetate derivative of DCFH. Upon entering cells the diacetate is cleaved enzymatically.
Both the DCFH-DA and DCFH are non-fluorescent fluorescein analogues. They are oxidized
to highly fluorescent 2’,7’-dichlorofluorescein (DCF) by H2O2 and hydroperoxides. The fluo-
rescence intensity was measured using a fluorometer at 485 nm excitation and 530 emission.
Splenocyte oxidative burst and phagocytosis–flow cytometry
Fixed Staphylococcus aureus (Trade name Pansorbin, Calbiochem, San Diego, CA) was stained
with propidium iodide (PI) and used to quantify phagocytosis. DCFH-DA was used to quan-
tify oxidative burst. Spleen cells were transferred into 5 ml tubes. DCFH-DA and PI-labeled
S. aureus were added to the cells and allowed to incubate. Fluorescence was detected using a
4-color FACSCaliburTM flow cytometer. Analysis of 5,000 events/tube was performed using
CellQuestTM software (v3.1).
Adrenal tissue homogenate
One adrenal gland from each mouse was weighed and homogenized using a Powergen homog-
enizer (Fischer Scientific, Tustin, CA) with 500 μl of phosphate-buffered saline (PBS), the
other adrenal was homogenized with 500 μl of 0.1M HClO4. The samples were spun at 12,000
x g for 15 min at 4˚C. The supernatant was aliquotted and frozen at -80˚C until assayed. The
supernatants were used to assess adrenocorticotropic hormone (ACTH) receptor. Samples
homogenized in HClO4 were used to assess corticosterone, protein, and catecholamines.
Total protein concentration in adrenals
Total protein concentration was quantified in the adrenals using a Pierce bicinchoninic acid
(BCA) Protein Assay kit (Thermo Fisher Scientific, Tustin, CA). Samples were run with pro-
tein standards ranging from 500 μg/ml to 7.8 μg/ml diluted with 0.1M HClO4.
Corticosterone via enzyme-linked immunosorbent assay (ELISA)
The adrenal glands from each mouse were homogenized. Supernatants were collected after
centrifugation and stored at -80˚C. Aliquots of frozen adrenal tissue supernatant were thawed,
diluted 1:10 in assay buffer, and corticosterone was measured using an ELISA kit for mouse
corticosterone from AssayPro (St. Charles, MO), according to manufacturer’s instructions.
Plates containing duplicate samples and standards were read on a microplate reader set at 450
nm. Corticosterone levels in adrenal supernatants were calculated from the standard curve
and expressed as means ± SEM in ng/mg protein. Cross reactivity for other steroids, such as
aldosterone or progesterone, was <2% or lower. Minimum detection of corticosterone by the
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kits was 0.156 ng/ml, and intra-assay and inter-assay variabilities were 5.0% and 7.1%,
respectively.
ACTH receptor via ELISA
ACTH receptors and phosphorylated ACTH receptors were assayed in adrenal gland homoge-
nates using ELISA kits from MyBiosource (San Diego, CA) as per the manufacturer’s instruc-
tions. Samples were run in duplicate along with known standards in 96-well plates at room
temperature. Plates were read on a plate reader set at 450 nm immediately after adding the
stop solution. Data were expressed as means ± SEM in pg/mg protein. The sensitivity of the kit
was 2.0 pg/ml. The detection range of the kit was 15.6–500.0 pg/ml. Intra-assay coefficient of
variation (CV) and inter-assay CV were less than 15%.
Catecholamines via high-performance liquid chromatography (HPLC)
Frozen aliquots of supernatant from adrenal tissue were thawed and diluted 1:5 in 0.1M
HClO4. Epinephrine, norepinephrine and dopamine were measured by HPLC using an ESA
582 isocratic pump, an ESA 542 autosampler, a Waters Atlantis T3 150 mm X 4.6 mm C18
reverse phase column, and an ESA Coulochem III detector with a 5011a cell set at +250 mV
and -200 mV. The mobile phase was a 100 μM citric acid/phosphate buffer with 20% methanol
pH 3.5. The assay volume was 50 μl. Values were expressed as a mean ± SEM in ng/mg
protein.
Metabolomics
Frozen liver samples were shipped to Metabolon, Inc. (Durham, NC) for analysis. Methanol
extraction of small molecules was carried out, as described previously [39, 40], using 100 mg of
liver tissue per sample. In addition, a small volume of each sample was utilized to create a
pooled liver sample that was prepared in parallel and included as a technical replicate to assess
variability and sensitivity in measurements, as described [39, 41]. The resulting extract was
divided into four fractions for non-targeted metabolomics analysis [39, 40, 42]: one for analysis
by ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/
MS; positive mode), one for analysis by UPLC-MS/MS (negative mode), one for analysis by
gas chromatography–mass spectrometry (GC-MS), and one sample was reserved for backup.
The UPLC-MS/MS platform utilized a Waters Acquity UPLC with Waters UPLC BEH
C18-2.1×100 mm, 1.7 μm columns and a ThermoFisher LTQ mass spectrometer, which
included an electrospray ionization source and a linear ion-trap mass analyzer. The instru-
mentation was set to monitor for positive ions in acidic extracts or negative ions in basic
extracts through independent injections. The instrument was set to scan 80–1000 m/z (molec-
ular weight) and alternated between MS and MS/MS scans. Samples destined for analysis by
GC-MS were dried under vacuum desiccation for a minimum of 18 hours prior to being deriv-
atized using bis(trimethylsilyl)trifluoroacetamide. Derivatized samples were separated on a 5%
diphenyl / 95% dimethyl polysiloxane fused silica column (20 m x 0.18 mm ID; 0.18 μm film
thickness) with helium as carrier gas and a temperature ramp from 60˚ to 340˚C in a 17.5 min
period. A Thermo-Finnigan Trace DSQ fast-scanning single-quadrupole MS using electron
impact ionization (EI) and operated at unit mass resolving power was utilized, and the scan
range was from 50–750 m/z.
Metabolites were identified by automated comparison of the ion features in the experimen-
tal samples to a reference library of chemical standard entries that included retention time,
molecular weight (m/z), preferred adducts, and in-source fragments as well as associated MS
spectra, and curated by visual inspection for quality control using software developed at
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Metabolon [43]. Identification of known chemical entities was based on comparison to
metabolomic library entries of more than 4,000 purified standards. Raw area counts for each
metabolite were re-scaled to set the medians to 1.0 for metabolites identified. Missing values,
assumed to be below the limit of detection of the platform used, were imputed with the
observed minimum after normalization. An estimate of the false discovery rate among metab-
olites identified as significantly different (p<0.05) between space flight livers and AEM con-
trols was calculated to be 22% when applying the q-value method of Storey and Tibshirani
[44].
RNA isolation
RNA isolation was performed using the RNeasy Mini Kit (Qiagen, Inc. Valencia, CA) as per
the manufacturer’s instructions. A maximum of 30-mg frozen liver/mouse tissue was used.
Target preparation/processing for GeneChip analysis
After isolation, RNA was frozen at -80˚C and shipped on dry ice to the University of Califor-
nia, Irvine (UCI) Genomics High-Throughput Facility (GHTF) for further analysis. The fol-
lowing protocol was provided by the UCI GHTF.
Isolated total RNA samples were processed as recommended by Affymetrix, Inc. (Affyme-
trix GeneChip Whole Transcript Sense Target Labeling Assay Manual, Affymetrix, Inc., Santa
Clara, CA). In brief, total RNA was initially isolated as described above and then put through
an RNeasy spin column (Qiagen, Chatsworth, CA) for further clean up. Eluted total RNAs
were quantified by NanoDrop (ThermoScientific, Wilmington, DE) and the concentrations of
sample aliquots were adjusted to 100 ng/μl. Total RNA samples were assessed for quality prior
to performing target preparation/processing steps by loading approximately 25–250 ng of each
sample onto a RNA 6000 Nano LabChip, which was evaluated on an Agilent Biolanalyzer 2100
(Agilent Technologies, Palo Alto, CA).
The Ambion whole transcript (WT) expression kit (Life Technologies, Carlsbad, CA) was
used to prepare RNA samples for whole transcriptome microarray analysis. Briefly, random
hexamers that were tagged with a T7 promoter were used in first strand synthesis of cDNA.
Then, using the T7 promoter, second strand synthesis was performed and the double-stranded
cDNA was subsequently used as a template in an in vitro transcription reaction to generate
many copies of antisense cRNA. Ten μg of antisense cRNA was input into a second cycle
cDNA reaction using reverse transcriptase and random hexamers to produce single-stranded
DNA in the sense orientation. The single-stranded DNA was fragmented to an average length
of 70 bases and then labeled using a recombinant terminal deoxynucleotidyl transferase (TdT)
and an Affymetrix proprietary DNA labeling reagent that was covalently linked to biotin.
Two μg of the labeled, fragmented single-stranded cDNA was hybridized at 45˚C with rotation
for 17 hours (Affymetrix GeneChip Hybridization Oven 640) to probe sets present on an Affy-
metrix GeneChip 1.0ST array. The GeneChip arrays were washed and then stained with strep-
tavidin-phycoerythrin on an Affymetrix Fluidics Station 450 (Fluidics protocol FS450_007).
Arrays were scanned using GeneChip Scanner 3000 7G and Command Console Software v.
3.2.3 to produce.CEL intensity files.
The probe cell intensity files (.CEL) were analyzed in Affymetrix Expression Console soft-
ware v1.1.1 using the Probe Logarithmic Intensity Error (PLIER) algorithm to generate probe
level summarization files (.CHP). The settings used were algorithm-PLIER v2.0; quantifica-
tion scale-Linear; quantification type-signal and detection P value; background-perfect match
GC composition-based background correction (PM-GCBG); normalization method-sketch-
quantile.
Spaceflight, immune dysfunction and metabolism
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Gene expression data were then processed via CARMAweb (Comprehensive R based
Microarray Analysis web service) using the significance analysis of microarrays (SAM) method
to get fold changes for determining differential expression and p values. The Benjamini-Hoch-
berg method was used to identify false positives. CARMAweb is a free, online tool hosted by
Medical University Innsbruck [45].
Histology and immunohistochemistry
PFA fixed, 5 μm tissue sections were processed for hematoxylin-and-eosin (H&E) staining and
immunofluorescence microscopy as described previously [46]. Additional histology sections
were processed for Periodic Schiff Stain (PAS) and Picrosirius Red stain. Immunoreactivity
was visualized using secondary antibodies conjugated with Alexafluor 488 or Alexafluor 594 at
dilutions of 1:500 and 1:250, respectively. Nuclei were stained with 4‘,6-diamidino-2-phenylin-
dole (Sigma). Immunofluorescence images were captured on a Nikon Diaphot fluorescence
microscope (Nikon Corporation, Tokyo, Japan) and digitally deconvolved using the No
Neighbors algorithm (Slidebook, Denver, CO) as described previously [46]. Histologic images
were captured on an Olympus BX51 microscope equipped with a four megapixel Macrofire
digital camera (Optronics, Goleta, CA) using the PictureFrame Application 2.3 (Optronics).
Cross-polarized light was also used to enhance visualization of Picrosiruis Red stained images
as previously described [47]. All images were cropped and assembled using Photoshop CS2
(Adobe Systems, Inc., Mountain View, CA).
Statistics
Functional analysis of gene expression data provided by the UCI GHTF was performed at LLU
using Ingenuity Pathway Analysis (IPA) software (Qiagen, Inc., Redwood City, CA). A z-score
of< -2.0 or > 2.0 was considered significant. A P value of overlap< 0.05, indicates that the
genes in our data set significantly overlap with the genes known to be involved with the func-
tion. Predicted effects are based on the literature and the measured effect of spaceflight. In
some cases, the down-regulation of a specific gene may lead to an increase in functional activ-
ity and vice versa. The z-score represents the combined predicted response of all genes known
to be explicitly involved in a particular function. All other data were analyzed using Sigmaplot
12.0 (Systat Software, Inc., San Jose, CA) with an unpaired T-test; P<0.05 and P<0.1 indicat-
ing significance and trending, respectively.
Results
Total body mass decreased after spaceflight but not significantly
There were no significant differences in total body mass at the time of sacrifice (AEM
19.5 ± 0.5 g, Flight 18.4 ± 0.5 g). Sample size: n = 8 for AEM ground controls, n = 7 for Flight.
However, when calculated as a difference from preflight, baseline mass, we previously reported
that spaceflight mice lost significantly more mass compared to AEM controls [35].
Decrease in splenocyte viability
There was a significant decrease in viability of splenocytes noted in the ground control mice
(P<0.001); 77% of splenocytes were viable in flight mice while only 68% were viable in ground
controls. The difference in viability was likely due to a problem with shipping fresh tissues
from the ground control mice from KSC to LLU (as described above). This difference in viabil-
ity, although relatively small, must be considered in interpreting all assays involving “fresh”
splenocytes presented below. Sample size: n = 8 for AEM ground controls, n = 5 for Flight.
Spaceflight, immune dysfunction and metabolism
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Spaceflight decreased major splenic leukocyte subset counts
There were significant flight-induced decreases in the total number of all major leukocyte pop-
ulations (P<0.001, S2 Fig). In terms of proportions, spaceflight caused a shift toward lympho-
cytes (P<0.001) away from granulocytes (P<0.001), with no significant impact on monocyte/
macrophage percentages.
Spaceflight decreased splenic lymphocyte subset counts
Spaceflight caused decreases in the total count of all measured lymphocyte subsets (S3 Fig)
including T (P<0.001), Th (P<0.001), Tc (P<0.005), B (P<0.001) and NK (P<0.05) cells. In
contrast, with the exception of an increase in Tc cells percentages (P<0.05), there was no sig-
nificant impact of spaceflight on the proportions of any lymphocytes. The proportional
increase in Tc cells led to a significant, flight-induced decrease in the CD4/CD8 ratio
(P<0.01), i.e., 1.6 for flight mice versus 2.0 for AEM ground controls.
Spaceflight increased splenic background ROS & oxidative burst but
decreased phagocytosis
As indicated in Fig 1, we characterized the capacity of cells present in the spleen to generate
an oxidative burst using both flow cytometry and a plate-based fluorescent assay. In both
cases, we found significant spaceflight-induced increases (P<0.001). In contrast, there were
Fig 1. Effects of spaceflight on splenocyte phagocytic function. Flow = Flow cytometry based assay. Plate = 96 well/fluorescence-
based assay. Values represent means ± SEM. N = 8 for Ground controls, 5 for Flight. *P<0.001.
https://doi.org/10.1371/journal.pone.0174174.g001
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decreases in phagocytic capacity in flight mice (P<0.001). Lastly, spaceflight increased the lev-
els of unstimulated, background ROS (P<0.001).
Spaceflight increased adrenal corticosterone, decreased ACTH
receptors, and did not impact catecholamine levels
We observed a trend for a spaceflight-induced increase in corticosterone levels in the adrenal
glands (P = 0.066, Fig 2). Although there were consistent decreases noted in ACTH receptors
(total or phosphorylated), these also did not reach significance. However, the corticosterone/
phosphorylated ACTH receptor ratio was greater in mice who experienced spaceflight
(P<0.05, See S1 Table).
There were no significant signs of spaceflight-induced changes in the adrenal catechol-
amines, norepinephrine and epinephrine (Fig 3). Similarly, although there was a slight eleva-
tion in dopamine in flight mice, this was not significant. However, this elevation resulted in
significant increases in the dopamine/norepinephrine ratio in spaceflight mice (P<0.05, See S1
Table). Spaceflight tended to decrease the norepinephrine/corticosterone and epinephrine/
corticosterone ratios (P = 0.068 and P = 0.056, respectively, S1 Table), but had no significant
impact on the dopamine/corticosterone ratio.
Spaceflight altered liver metabolite levels
We performed untargeted metabolite profiling in the liver, comparing spaceflight and AEM
ground controls. The effect of spaceflight on energy and lipid metabolism in these mice has
been recently described [35]. Metabolites relevant to the current discussion are included in
Table 1. We found significant increases in corticosterone as well as changes in some of the
components of glutathione (GSH) synthesis. Specifically, there were decreases in GSH with
corresponding increases in 2-aminobutyrate and ophthalmate, potentially indicative of
increased oxidative stress. Osmolyte concentrations were altered, with increases in betaine and
taurine, and decreases in alanine, glycerophosphorylcholine (GPC) and hypotaurine observed.
Finally, we found an increase in glycerol and decreased levels of 3-indoxyl sulfate, a measure of
kidney function commonly characterized in the blood.
Fig 2. Effects of spaceflight on corticosterone and ACTH receptor levels in the adrenal gland. Corticosterone was quantified via
ELISA. Values represent means ± SEM. N = 8 for Ground controls, 5 for Flight. T = trend, P = 0.066. ACTH receptor (ACTH-r) levels
quantified via ELISA. p-ACTH-r = phosphorylated ACTH-r. Values represent means ± SEM. N = 11 for Ground controls, 7 for Flight.
https://doi.org/10.1371/journal.pone.0174174.g002
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PLOS ONE | https://doi.org/10.1371/journal.pone.0174174 May 24, 2017 9 / 22
Spaceflight altered liver gene expression patterns related to innate
immunity, oxidative stress and metabolism
Although we performed a full genomic screen of changes in mouse liver gene expression after
spaceflight, we present only a subset of the data here. Similarly, although there are multiple
methods for analyzing the data (e.g. basic fold changes, pathway analysis, upstream transcrip-
tion regulation analysis, etc.), here we focus on genes identified though a functional analysis
via IPA. This analysis allowed us to identify genes that are both functionally related (based on
the current state of the literature) and statistically correlated to spaceflight. This analysis takes
into consideration that, in some cases, down-regulation of a particular gene may actually lead
to the activation of a particular function, or vice versa.
Fig 3. Effects of spaceflight on catecholamine levels in the adrenal gland. Catecholamines measured via
HPLC. EPI = epinephrine. NE = Norepinephrine. DA = dopamine. Values represent means ± SEM. N = 13 for
Ground controls, 7 for Flight.
https://doi.org/10.1371/journal.pone.0174174.g003
Table 1. Effects of spaceflight on liver metabolomics. Values represent fold changes over AEM controls. All other values are significant (P<0.05). Analy-
sis provided by Metabolon, Inc.
Function Metabolite Fold Change
Steroid Synthesis Corticosterone 1.51
Glutathione (GSH) Synthesis 2-aminobutyrate 1.62
Cystathionine -1.39
Cysteinylglycine (cys-gly) -1.43
Glutathione, reduced (GSH) -1.85
Ophthalmate 2.33
Osmolyte Alanine -1.30
Betaine 1.83
Glycerophosphorylcholine (GPC) -3.57
Hypotaurine -1.43
Taurine 1.17
Kidney 3-indoxyl sulfate -1.96
Gluconeogenesis Glycerol 1.42
https://doi.org/10.1371/journal.pone.0174174.t001
Spaceflight, immune dysfunction and metabolism
PLOS ONE | https://doi.org/10.1371/journal.pone.0174174 May 24, 2017 10 / 22
Table 2 lists a subset of the immune and oxidative stress-related functions identified by IPA
to be significantly altered in the liver by spaceflight (z-score >2.0 for activation, <-2.0 for
deactivation). Generally, spaceflight appears to have up-regulated functions related to viral
infections (z > 4.2) and infections of cells (z > 2.8). Likely linked to this is the activation of cla-
thrin- and receptor-mediated endocytosis (z > 3.1 and z > 2.7, respectively), fusion of late
endosomes (z> 2.1) and formation of peroxisomes (z > 2.1).
Surprisingly, despite the increase in activity related to viral infection, there is a down-regu-
lation in the functional activation of CD8+ T lymphocytes (z < -2.0). Furthermore, although
z-scores did not reach the level of significance, there also are trends for the down-regulation of
functions related to oxidative stress and ROS metabolism (z < -1.7).
Table 3 describes the functional analyses of genes in the liver related to glycolysis and lipid
metabolism. In general, functions related to the generation and sequestration of glucose are
up-regulated (z > 2.0) by spaceflight, while functions related to glycolysis are down-regulated
(z< -2.0). There are also strong trends for increases in functions that involve the oxidation of
lipids (z > 1.8).
Microarray fold-changes summarized in Table 4 reveal that expression of regulators of gly-
cogen synthesis, such as glycogen synthase (Gys2), protein phosphatase 1 catalytic subunits
(Ppp1ca, Ppp1cb), Gbe1, Foxo1 and Gsk3b were augmented and glycogen phosphorylase
(Pygl) mRNA expression was decreased. PEPCK (Pck1) was unchanged. Since insulin is asso-
ciated with increased glycogen storage, we also performed IPA analysis on expression of gene
transcripts in the insulin signaling pathway and found that gene expression levels were
decreased in the flight mice for IRS1, IRS2, PI3K and much of the MAPK pathway (S4 Fig).
Spaceflight mice lose glycogen stores in liver
Periodic Acid Schiff (PAS) staining of fixed liver tissue sections was performed on n = 4–5
mice per group. Representative images are shown in Fig 4. Inspection of the stained sections
revealed a profound loss of glycogen staining in the flight mice (panel B) as compared with
AEM controls (panel A), supporting the microarray results.
Table 2. Spaceflight effect on immune-related liver gene expression based on functional analysis. Functional analysis was performed with IPA soft-
ware. Activation z score = statistical value representing the activation state. Z > 2.0 or <-2.0 is generally considered significant. P value = P-value of overlap, a
statistical representation describing the level of overlap of genes in our data set compared to the total number of genes known to be directly involved in a partic-
ular function based on the literature. # molecules = Number of genes in our data set known to be directly involved in a particular function based on the litera-
ture. A complete description of the analysis can be found on the IPA website (http://www.ingenuity.com/).
Function Activation z-score Predicted Activation State p-Value # Genes
Viral Infection 4.278 Increased 2.34E-06 335
Clathrin-Mediated Endocytosis 3.125 Increased 1.70E-02 20
Infection of Cells 2.838 Increased 5.61E-04 139
Receptor-Mediated Endocytosis 2.775 Increased 2.21E-02 23
Formation of Peroxisomes 2.191 Increased 6.78E-03 6
Fusion of Late Endosomes 2.183 Increased 1.90E-02 6
Activation of CD8+ T Lymphocyte -2.000 Decreased 7.00E-03 5
Senescence of Cells -2.555 Decreased 2.96E-02 61
Trends
Oxidative Stress Response of Cells -1.773 Decreased 8.88E-03 18
Cell Death of Granulocytes -1.794 Decreased 3.83E-02 26
Metabolism of Reactive Oxygen Species -1.796 Decreased 3.31E-02 106
Stress Response of Cells -1.948 Decreased 1.34E-03 33
Synthesis of Reactive Oxygen Species -1.984 Decreased 3.52E-02 104
https://doi.org/10.1371/journal.pone.0174174.t002
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Discussion
Spaceflight appears to have had a significant impact on both immune and metabolomic func-
tion. These differences occur in the cell count and proportion data (see S1 Discussion), cell
function, metabolites and in gene expression. As we will show, be believe these changes do not
occur independently and are, in fact, linked.
There were increases in background ROS levels measured in splenocytes ex vivo after flight,
suggesting an increase in oxidative stress. High oxidative stress would be consistent with our
results from STS-118 where we found increases in the expression of several genes in the liver
involved in ROS scavenging and metabolism [5]. This would also be consistent with the
increase in the GSSG:GSH ratio (due to the decrease noted in GSH levels) found in metabolo-
mic analysis of the spaceflight livers noted here.
However, although there was an increasing trend noted in another marker of oxidative
stress, cysteine-glutathione disulfide, this did not reach the level of significance (Table 1). Fur-
thermore, the increase in GSSG:GSH ratio was due primarily to a decrease in GSH with no
corresponding increase in GSSG. While the decrease noted in cysteinyl-glycine (cys-gly) sug-
gests that there may be less GSH breakdown with spaceflight, there were no significant changes
in any of the quantified γ-glutamyl amino acids, nor in any other metabolic components of the
cycle, including 5-oxoproline, glutamate, cysteine, or glycine. This suggests a more likely
explanation for the observed metabolite changes is that there was a decrease in GSH synthesis
leading to a lower capacity to deal with oxidative stress.
The enzymes responsible for converting glutamate, cysteine, and glycine into GSH are glu-
tamyl-cysteine synthetase (GCS) and glutathione synthetase (GS) (Fig 5). These enzymes are
also part of another, separate branch of the pathway responsible for converting cystathionine
(a precursor for cysteine) into ophthalmate. This is critical because although cystathionine
Table 3. Spaceflight effect on liver expression for genes involved in carbohydrate and lipid metabolism. Functional analysis was performed with IPA
software. Activation z score = statistical value representing the activation state. Z > 2.0 or <-2.0 is generally considered significant. P value = P-value of over-
lap, a statistical representation describing the level of overlap of genes in our data set compared to the total number of genes known to be directly involved in a
particular function based on the literature. # molecules = Number of genes in our data set known to be directly involved in a particular function based on the lit-
erature. A complete description of the analysis can be found on the IPA website (http://www.ingenuity.com/).
Function Activation z-score Predicted Activation State p-Value # Genes
Incorporation of D-Glucose 2.000 Increased 3.93E-02 6
Synthesis of Phosphatidylserine 2.000 Increased 1.51E-03 5
Beta-Oxidation of Fatty Acid 2.153 Increased 2.00E-02 17
Concentration of Choline-Phospholipid 2.154 Increased 1.27E-02 14
Synthesis of D-Glucose 2.302 Increased 3.44E-02 21
Synthesis of Monosaccharide 2.463 Increased 2.76E-02 22
Uptake of Fatty Acid 2.754 Increased 1.67E-02 19
Glycolysis of Carbohydrate -2.758 Decreased 1.36E-02 9
Glycolysis of D-Glucose -2.571 Decreased 2.91E-02 8
Glycolysis -2.548 Decreased 8.88E-03 18
Concentration of Fatty Acid -2.541 Decreased 2.11E-02 69
Disorder of Lipid Metabolism -2.040 Decreased 9.39E-03 58
Trends
Oxidation of Lipid 1.843 Increased 1.31E-03 56
Oxidation of Fatty Acid 1.891 Increased 2.53E-03 44
Biliary Excretion of Lipid 1.963 Increased 2.16E-02 4
Hydrolysis of Diacylglycerol 1.980 Increased 2.16E-02 4
Concentration of Phosphatidylcholine 1.989 Increased 2.82E-02 11
https://doi.org/10.1371/journal.pone.0174174.t003
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decreased, both ophthalmate and its upstream precursor, 2-aminobutyrate, significantly
increased after flight. This suggests that factors related to spaceflight are driving the kinetics of
GCS towards ophthalmate production.
Interestingly, ophthalmate is an endogenous analog of GSH and may be a biomarker for
oxidative stress and GSH depletion [48, 49]. Consistent with these reports is the possibility that
chronic exposures to the spaceflight environment could lead to a situation where GSH is
depleted to such an extent that corresponding increases in downstream products such as
GSSG and γ-glutamyl-AA is no longer possible. However, this would not be consistent with
our transcriptomics analysis discussed above. Further study is required to clarify these
findings.
As indicated in Fig 5, this switch in priorities is further suggested by our liver gene ex-
pression analysis. While there was no change in the expression of the GS gene, there was a sig-
nificant decrease in GCS expression, confirming that GSH synthesis was down-regulated.
Although there was a trend for a decrease in the expression of cystathionase, the enzyme for
breaking cystathionine into cysteine + α-ketobutyrate, we were not able to identify the specific
transaminase responsible for converting α-ketobutyrate into 2-aminobutyrate.
Taken together, these results suggest that although there was an overall decrease in
cystathionine, some other mechanism(s) may be driving the remaining resources toward the
Table 4. mRNA expression changes in the liver for selected genes involved in glycogen metabolism. Fold changes, P and q values are calculated
using CARMAWeb. P < 0.05 is considered significant. The Entrez accession number is given by entrezid.
entrezid q p FLT/AEM
(log2)
Foxo1 56458 3.15E-03 1.26E-04 0.440
Gbe1 74185 5.44E-02 2.19E-02 0.405
Gys2 232493 9.93E-02 5.94E-02 0.359
Ppp1cb 19046 9.51E-02 5.51E-02 0.294
Ppp1ca 19045 2.49E-02 6.22E-03 0.259
Gsk3b 56637 1.39E-01 1.06E-01 0.148
Pck1 18534 3.72E-01 5.93E-01 0.030
Pygl 110095 1.01E-02 1.25E-03 -0.204
https://doi.org/10.1371/journal.pone.0174174.t004
Fig 4. Effects of spaceflight on hepatic glycogen stores. Liver tissue was fixed using 4% paraformaldehyde
and stained with Periodic Acid Schiff stain to visualize glycogen. PT = portal triad, CV = central vein. A
representative image from n = 5 mice per group is shown.
https://doi.org/10.1371/journal.pone.0174174.g004
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generation of more ophthalmate. Why this should occur is not entirely clear. However, others
have reported that ophthalmate levels are increased in the liver when GSH is depleted and the
supply of cysteine to the liver is depleted [48]. The end result is a reduction in the level of GSH
available to scavenge ROS.
Despite these changes in individual genes, functional analysis of the liver genes via IPA did
not indicate any generalized, consistent increases in overall oxidative stress responses. In fact,
hepatocyte-specific oxidative stress response functions all trended toward being slightly down-
regulated (Table 2). This suggested that something other than oxidative stress may be going
on.
Another possible explanation is that overall transaminase (or aminotransferase) levels
increased as a consequence of muscle atrophy. Among other things, transaminases are
involved in breaking proteins down into amino acids when blood sugar levels are low, usually
at the expense of muscle tissue. This is interesting because spaceflight is known to induce
muscle atrophy, in general, and was recently reported to do so in these mice specifically [50].
Unfortunately, we were unable to identify the specific transaminase responsible for converting
α-ketobutyrate into 2-aminobutyrate (Fig 5) and cannot verify this hypothesis.
In addition to the increases in background ROS levels in splenocytes, there were large
increases in the capacity to generate an oxidative burst in the splenocytes, despite the large
decreases in cell counts. Because we did not isolate phagocytic populations for these ex vivo
Fig 5. Effects of spaceflight on GSH production. This figure represents a combination of data generated through genomics and
metabolomics. CTH = cystathionase. cys-gly = cysteinylglycine. GCS = glutamyl-cysteine synthase. GGT = gamma-glutamyl transpeptidase.
GS = glutathione synthase. GSH = glutathione. GSSG = glutathione (oxidized). Rectangles represent metabolomics data. Ovals represent
genomics data. Grey = unchanged. Green = down-regulated. Red = up-regulated. Blue = specific transaminase unidentified.
https://doi.org/10.1371/journal.pone.0174174.g005
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assays, the proportion of cells in the spleen after flight is of critical importance in interpreting
this result. However, increases in burst activity occurred in spite of decreases in granulocyte
proportions (and no change in monocyte/macrophages) suggesting that the respiratory burst
activity of the cells themselves increased.
There is very little in the literature describing the impact of spaceflight on ex vivo burst
activity in splenocytes after spaceflight. Kaur et al. reported decreases in burst capacity in both
monocytes [51] and neutrophils [52] from the blood of astronauts collected immediately after
landing. Although we did not have the opportunity to measure oxidative burst capacity in the
blood of our mice, this difference in response suggests that either the response is organ-specific
and/or primed populations specifically traffic to lymphoid organs, such as the spleen.
An increase in induced respiratory burst activity would be consistent with our liver gene
expression data which showed a functional up-regulation in the formation of peroxisomes and
the fusion of late endosomes (Table 2). However, as mentioned previously, there was a down-
regulation in functions related to ROS metabolism. Interestingly, peroxisomes and late endo-
somes are also involved in lipid processing and metabolism, suggesting the increases in these
cellular components may also reflect a change in gluconeogenesis [53].
Despite the increases in ROS activity, we found decreases in overall phagocytic activity in
splenocytes after flight. Because this assay was performed ex vivo with a constant number of
cells, and because we also saw decreases in some phagocyte proportions (e.g. granulocytes), a
possible explanation for this decrease is a change in population distributions. However, the
decrease in phagocytic activity (as measured by flow cytometry) was roughly 50% while the
decrease in granulocyte percentage was only about 3%. We believe that it is unlikely that such
a drastic decrease in phagocytic capacity would be due to such a small decrease in phagocyte
proportions. Furthermore, decreases in phagocytic capacity have also been reported in both
the macrophages and neutrophils in the blood of astronauts immediately after landing
[51, 52].
One possible explanation for the changes in immunocyte distribution and function is psy-
chological/physiological stress. In support of this is the trend for a spaceflight-induced up-reg-
ulation of adrenal levels of corticosterone, an indicator of increased hypothalamus-pituitary-
adrenal (HPA) activity. Metabolomic analysis of both the liver (presented here) and skin [54]
of these mice showed similar increases in corticosterone levels. This is also generally consistent
with reports of post-flight increases in circulating corticosterone levels in rodent models [7, 17,
26, 55]. A very recent study showed that cortisol levels generally increased in astronaut saliva
in-flight compared to pre-flight levels, but this was only a trend [56]. Surprisingly, cortisol lev-
els typically do not change in the blood of astronauts post-flight [31, 32, 57, 58]. There are even
at least two reports of decreases in plasma cortisol levels in astronauts due to flight [59, 60]. In
contrast, urinary cortisol levels typically increased after flight [31, 32, 57–61], but not always
[51].
Since corticosterone is synthesized and released in the adrenal cortex and most endocrine
tissues have tightly regulated homeostatic mechanisms that keep tissue levels within small
discrete ranges (i.e., the amount of hormone being made is the same amount as that being
released–allostasis), measuring adrenal corticosterone is not equivalent to measuring it in the
blood or other organs. This suggests that the small difference in adrenal corticosterone levels
between treatment groups reported here, despite fairly consistent increases found in other tis-
sues, may actually be due to an increase in corticosterone synthesis in the adrenal cortex to
compensate for increased corticosterone secretion into the circulation.
Decreases in spleen and thymus mass have long been associated with chronically elevated
levels of corticosterone and stress [62–64]. We previously reported consistent decreases in
spleen and thymus mass in these mice [1], as well as in rodents flown on STS-77 [18], -108 [2]
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and -118 [5]. While others have also reported decreases in spleen mass after flight [7, 9, 12, 14,
17], there is at least one report of an increase [55]. Similarly, thymus mass has generally been
shown to decrease after flight [9, 12, 17], but there are some reports of increases [17, 55].
If spaceflight-subjected mice were indeed stressed as other findings here and in the litera-
ture suggest, particularly during the landing, then this should be reflected in ACTH activity.
Adrenal corticosterone secretion is known to be up-regulated by ACTH receptor ligation on
adrenocortical cells (predominantly in the zona fasciculata). An increase in corticosterone
should be coincident with an increase in ACTH levels. Indeed, while plasma ACTH levels did
not change in the blood of astronauts after flight [32, 58, 60], urinary ACTH levels increased
[32].
Although we did not characterize adrenal ACTH levels directly, we did measure ACTH
receptors. Because ACTH receptors are unique G protein-coupled receptors in that ligand acti-
vation up-regulates their expression [65–68], this should provide an indirect measure of
ACTH activity and HPA activation. However, we did not find significant effects of spaceflight
on ACTH receptor expression. Similarly, the percentage of phosphorylated ACTH receptors
in the adrenals did not differ between treatment groups after flight. This would seem to suggest
that the chronic exposure to the conditions of spaceflight promotes receptor desensitization
and suggests that spaceflight may actually reduce the sensitivity to stress.
Adrenal catecholamines are mediators of stress-induced activation of the sympathoad-
renomedullary (SAM) axis, and like corticosterone, their production and secretion into the
circulation typically increases in response to stress. However, despite the noted increases in
corticosterone, we found no changes in adrenal norepinephrine and epinephrine levels. There
is very little published in the literature involving activation of the SAM axis after spaceflight in
rodent models. However, norepinephrine levels in the kidney of rats either do not change [69]
or actually decreased [70] after spaceflight. Interestingly, urinary epinephrine levels did not
change [31, 51, 52] or increased [32, 57, 60, 61] in astronauts after flight. Similarly, urinary
norepinephrine levels either did not change [51, 52] or increased [31, 32, 57, 60]. Because uri-
nary catecholamine levels are usually assessed using pooled samples collected over a 24-hour
period post-landing, we believe that the reported increases are reflective of a response to the
landing and not the actual spaceflight environment.
These data suggest that while there may have been an activation of stress pathways after
spaceflight, the response was relatively mild and likely did not involve both HPA and SNS acti-
vation. Although speculative, given the lack of a significant catecholamine response, it is possi-
ble that this elevation in corticosterone is not directly related to psychological stress at all. But
rather, the change is related to energy balance and lipid metabolism. As previously stated,
spaceflight has long been suspected to alter energy metabolism [71] and stress hormones like
glucocorticoids (i.e. corticosterone) are known to play a significant role in metabolism [72,
73]. Indeed, corticosterone promotes fat breakdown in adipose and muscle tissue to provide
glycerol to the liver for gluconeogenesis. Consistent with this idea is the fact that the metabo-
lite, glycerol, was also more abundant in flight liver relative to ground controls.
Interestingly, peroxisome proliferator-activated receptor gamma (PPAR) regulated activity
increased significantly in the liver after flight. This is important because although the primary
function of PPARs is to regulate lipid metabolism, PPARs can also negatively interfere with
immune regulators including NF-κB, STAT, and AP-1 signaling pathways [74–79]. PPARs
also mediate macrophage responses in the arterial cell wall [76, 77, 80, 81], both by interfering
with chemoattraction and adhesion of immunocytes, including T cells and monocytes, and by
down-regulating MCP-1 [82], RANTES [83], and vascular cell adhesion molecule-1 (VCAM-
1) [75, 84]. We have demonstrated that lipid metabolism and PPAR activity are altered in
spaceflight [35]. Given that many of the functional changes we see in immune response overlap
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considerably with energy/lipid metabolism, we believe that the two phenomena may actually
be related.
We observed a profound loss of glycogen stores in the livers of Flight mice. Paradoxically,
most regulators of glycogen synthesis were increased, concomitant with a decrease in glycogen
phosphorylase mRNA expression, pointing to upregulation of glycogenic rather than glyco-
genolytic pathways. This may be due, in part, to activation of compensatory mechanisms for
restoring normal levels of glycogen stores. PEPCK (Pck1) mRNA expression was unchanged;
therefore gluconeogenesis as a mechanism for restoring glycogen was likely not activated. We
did not observe changes in hepatic glucose or glucose-6-phosphate concentrations and unfor-
tunately did not have access to blood to measure serum glucose or insulin levels. However,
the intracellular downregulation of IRS, PI3K and MAPK pathway genes are classical post-
receptor manifestations of insulin resistance that may be induced by lipotoxicity, as we have
previously shown [35]. Taken together, our data support the concept of spaceflight-induced
alterations in the response to insulin that may correlate with insulin resistance. It will be
important to obtain serum in future studies to measure insulin levels in mice and further pur-
sue this link.
In conclusion, spaceflight clearly causes transient changes in immune function. However,
the cause may not be exclusively due to psychological or oxidative stress. But rather, the shifts
in immune function may be at least partially due to shifts in energy needs in space. Onset of
leukocyte regeneration after landing could, of course, also have a significant impact on func-
tional status. As a full description of the impact of spaceflight on lipid metabolism is beyond
the scope of this paper, the details of this have been covered elsewhere [35]. However, gene
expression functional analysis indicated increases in functions related to glucose synthesis and
sequestration, with corresponding decreases in glycolysis functions. Furthermore, the ex vivo
increases in ROS activity, combined with corresponding increases in peroxisome and endo-
some-related gene expression, are likely related to spaceflight-induced shifts in lipid metabo-
lism. This further suggests that spaceflight causes a shift in priorities in phagocytic populations
away from antigen processing toward lipid processing, potentially increasing risk for infection.
Supporting information
S1 Fig. Proposed model linking spaceflight-induced disruptions in innate immune func-
tion and metabolism.
(TIF)
S2 Fig. Effects of spaceflight on splenic leukocyte populations. Data were obtained using an
automated hematology analyzer. Values were normalized to daily Vivarium controls. WBC =
white blood cells. LYM = lymphocytes. MON = monocyte/macrophages. GRA = granulocytes.
Values represent means ± SEM. N = 8 for Ground controls housed in animal enclosure mod-
ules, 5 for Flight. P<0.001.
(TIF)
S3 Fig. Effects of spaceflight on lymphocyte subsets. Values represent means ± SEM. N = 8
for Ground controls, 5 for Flight. Values were normalized to daily Vivarium controls.
P<0.05, P<0.005, P<0.001.
(TIF)
S4 Fig. Impact of spaceflight on the insulin signaling pathway. Analysis performed using
Ingenuity Pathway Analysis (Qiagen, Inc., Redwood City, CA). Grey = unchanged. Green =
down-regulated. Red = up-regulated.
(TIF)
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S1 Table. Effect of spaceflight on hormone ratios. Values represent means ± SEM. N = 13
for Ground controls, 7 for Flight. NS = Not significant.
(DOCX)
S1 Discussion. Effect of spaceflight on splenic immunocyte population distributions. We
have analyzed splenic immunocyte populations on three separate space shuttle missions with
very similar flight profiles. This additional discussion includes historical context as well as
comments on repeatability.
(DOCX)
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